ScienceDaily (Oct. 28, 2006) — Montréal scientists led by Dr Jacques Drouin, researcher at the Institut de recherches cliniques de Montréal (IRCM), and collaborators from around the world (Canada, France, the Netherlands and United States) unravel mechanism of hormone resistance in pituitary tumors of Cushing disease patients.

Cushing disease is caused by pituitary tumors that produce excessive amounts of hormone because the tumor cells have become resistant to negative feedback control by a class of steroid hormones, glucocorticoids. In Cushing disease, this excessive hormone production can lead to hypertension, obesity, diabetes and osteoporosis. Through detailed molecular investigation of the mechanism of this negative feedback, a Montréal research group has identified two essential components (proteins) of this feedback mechanism. Extrapolating from these basic studies, they have shown that about half of the pituitary tumors from Cushing disease patients are deficient in expression of either of these proteins, thus providing a molecular explanation for the hormone resistance that is the hallmark, and likely first event, in the formation of these tumors. The novel insight provided by knowledge of the basic mechanism of hormone resistance will lead to the rational design of therapeutic approaches for the better management of Cushing disease patients. This insight will also help understand other forms of hormone resistant cancers.

Dr. Jacques Drouin is the Director of the Molecular Genetics Research Unit at IRCM. He holds the GlaxoSmithKline Chair in Molecular Genetics. The IRCM (http://www.ircm.qc.ca) is recognized as one of the country's top-performing research centres. It has a mandate to establish links between research and patients, promote the prevention of illness, and train a new generation of high-level scientists. The IRCM has 37 research units and a staff of more than 450. The IRCM is also affiliated to Université de Montréal.

This work is published in Genes and Development (Bilodeau et al, Genes Dev 2006, 20:2871-2886) and it was supported by grants from the Canadian Cancer Society and from the Canadian Institutes of Health Research.

Related Stories

Patients With Mild Cushing Syndrome May Benefit From Adrenalectomy (Dec. 10, 2007) — Patients with a mild form of Cushing syndrome, a metabolic disorder caused by adrenal tumors, showed substantial clinical improvement after adrenalectomy. The study is the largest series of surgical ...  > read more

Tumor 'Stem-like Cells' Exist In Benign Tumors (July 28, 2009) — Cancer stem-like cells have been implicated in the genesis of a variety of malignant cancers. Research scientists have now isolated stem-like cells in benign (pituitary) tumors and used these ...  > read more

Gene Predisposing To Pituitary Tumors Identified (May 25, 2006) — A recent study identifies a low-penetrance gene defect which predisposes carriers to intracranial tumors called pituitary adenomas. In particular individuals carrying the gene defect are susceptible ...  > read more

Fireflies And Jellyfish Help Illuminate Quest For Cause Of Infertility (Apr. 11, 2009) — Genes taken from fireflies and jellyfish are literally shedding light on possible causes of infertility and autoimmune diseases in humans. Scientists are using the luminescent and fluorescent genes ...  > read more

Search ScienceDaily

Helping Cancer Survivors Grow Up